(Q2)Feb 29, 2024 | (Q1)Nov 30, 2023 | (FY)Aug 31, 2023 | (Q4)Aug 31, 2023 | (Q3)May 31, 2023 | (Q2)Feb 28, 2023 | (Q1)Nov 30, 2022 | (FY)Aug 31, 2022 | (Q4)Aug 31, 2022 | (Q3)May 31, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow (Indirect Method) | ||||||||||
Cash flow from continuing operating activities | 69.59%-5.01K | 65.61%-31.33K | 53.19%-188.69K | 56.96%-44.34K | 53.36%-36.78K | 84.40%-16.48K | 21.18%-91.09K | 33.42%-403.12K | 24.00%-103.01K | 47.90%-78.85K |
Net income from continuing operations | 38.45%-107.04K | -2.18%-110.98K | 86.76%-664.48K | 95.80%-183.18K | 10.01%-198.77K | 27.81%-173.91K | 45.74%-108.62K | -561.02%-5.02M | -1,210.57%-4.36M | -146.44%-220.89K |
Asset impairment expenditure | ---- | ---- | -99.37%27.03K | -100.00%1 | ---- | ---- | ---- | 2,373.66%4.32M | --4.32M | ---- |
Other non cashItems | -52.34%51.4K | 104.75%51.05K | 10.83%353.79K | 278.40%105.08K | -14.51%115.93K | -13.36%107.84K | -78.87%24.93K | 579.70%319.21K | ---58.9K | --135.61K |
Change In working capital | 2.12%50.63K | 485.94%28.6K | 550.05%94.96K | 796.10%33.75K | 195.96%19.03K | 361.06%49.58K | 77.83%-7.41K | 30.96%-21.1K | -138.99%-4.85K | 110.42%6.43K |
-Change in receivables | -106.32%-2.49K | 30.37%-2.93K | 262.37%28.54K | 20.02%-3.87K | 39.31%-2.77K | 899.09%39.4K | -29.85%-4.21K | 65.31%-17.58K | 10.76%-4.84K | -38.04%-4.56K |
-Change in prepaid assets | --0 | --0 | 2,200.00%10.5K | --0 | --0 | --0 | 5.00%10.5K | 92.04%-500 | --0 | --0 |
-Change in payables and accrued expense | 421.49%53.12K | 330.18%31.53K | 1,950.81%55.91K | 752,660.00%37.63K | 98.33%21.8K | -61.09%10.19K | 65.91%-13.7K | -111.45%-3.02K | -100.02%-5 | 118.82%10.99K |
Cash from discontinued investing activities | ||||||||||
Operating cash flow | 69.59%-5.01K | 65.61%-31.33K | 53.19%-188.69K | 56.96%-44.34K | 53.36%-36.78K | 84.40%-16.48K | 21.18%-91.09K | 33.42%-403.12K | 24.00%-103.01K | 47.90%-78.85K |
Investing cash flow | ||||||||||
Cash flow from continuing investing activities | 0 | 95.29%-194.4K | ||||||||
Net other investing changes | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 95.29%-194.4K | ---- | ---- |
Cash from discontinued investing activities | ||||||||||
Investing cash flow | ---- | ---- | --0 | ---- | ---- | ---- | ---- | 95.29%-194.4K | ---- | ---- |
Financing cash flow | ||||||||||
Cash flow from continuing financing activities | 21.83K | 30K | -40.00%30K | 30K | 0 | 0 | 0 | -99.06%50K | 0 | |
Net issuance payments of debt | --21.83K | --30K | --30K | ---- | ---- | --0 | --0 | --0 | ---- | ---- |
Net common stock issuance | ---- | ---- | --0 | ---- | ---- | ---- | ---- | -98.65%50K | ---- | ---- |
Cash from discontinued financing activities | ||||||||||
Financing cash flow | --21.83K | --30K | -40.00%30K | --30K | --0 | --0 | --0 | -99.06%50K | --0 | ---- |
Net cash flow | ||||||||||
Beginning cash position | -93.08%5.12K | -96.09%6.45K | -76.83%165.15K | -95.51%20.79K | -88.29%57.57K | -87.60%74.05K | -76.83%165.15K | 387.45%712.67K | 92.96%462.57K | -71.46%491.42K |
Current changes in cash | 202.00%16.81K | 98.54%-1.33K | 71.02%-158.69K | 95.18%-14.34K | -27.48%-36.78K | 84.40%-16.48K | 21.18%-91.09K | -196.66%-547.53K | -162.88%-297.42K | 98.05%-28.85K |
End cash Position | -61.90%21.94K | -93.08%5.12K | -96.09%6.45K | -96.09%6.45K | -95.51%20.79K | -88.29%57.57K | -87.60%74.05K | -76.83%165.15K | -76.83%165.15K | 92.96%462.57K |
Free cash from | 69.59%-5.01K | 65.61%-31.33K | 53.19%-188.69K | 56.96%-44.34K | 53.36%-36.78K | 84.40%-16.48K | 21.18%-91.09K | 33.42%-403.12K | 24.00%-103.01K | 47.90%-78.85K |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
No Data